Prediction of exacerbations in patients with COPD

E-poster
Chairs: C. Bal (Wien, Austria), T. Lapperre (Antwerp, Belgium)
Aims: This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.

Implementation of an integrated care model for fragile COPD patients: a controlled prospective study H. Shafiek (Alexandria, Egypt), J. Verdú (Palma de Mallorca, Spain), F. Fiorentino (Palma de Mallorca, Spain), J. Valera (Palma de Mallorca, Spain), R. Martínez (Palma de Mallorca, Spain), S. Romero (Palma de Mallorca, Spain), L. Ramon-Clar (Palma de Mallorca, Spain), N. Toledo-Pons (Palma de Mallorca, Spain), E. Sala (Palma de Mallorca, Spain), B. Cosio (Palma de Mallorca, Spain)
Increased Exacerbations of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Carriers M. Goldklang (New York, United States of America), K. Law (New York, United States of America), A. Gerber (New York, United States of America), J. Olsen (New York, United States of America), C. Henry (New York, United States of America), G. Wagener (New York, United States of America), J. D'Armiento (New York, United States of America)
Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators F. Lu (Shanghai, China), R. Chen (Shanghai, China), N. Li (Shanghai, China), X. Sun (Shanghai, China), M. Zhou (Shanghai, China), Q. Li (Shanghai, China), Y. Guo (Shanghai, China)
Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK H. Whittaker (London, United Kingdom), A. Rubino (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), T. Morris (Luton, United Kingdom), P. Varghese (Gaithersburg, MD, United States of America), Y. Xu (Luton, United Kingdom), E. De Nigris (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
Predicting 12-month mortality in a Scottish COPD cohort S. Burns (Edinburgh, United Kingdom), D. Lowe (Glasgow (Glasgow), United Kingdom), A. Taylor (Glasgow (Glasgow), United Kingdom), P. Mcginness (Edinburgh, United Kingdom), C. Carlin (Glasgow (Glasgow), United Kingdom)
Patient characteristics and invasive ventilation decisions in ECOPD S. Gillespie (Newcastle Upon Tyne, United Kingdom), N. Lane (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), K. Frew (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom)
Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis R. Lundgren (Stockholm, Sweden), K. Andelid (Göteborg, Sweden), M. Ezerskyte (Stockholm, Sweden), N. Pournaras (Stockholm, Sweden), B. Brundin (Stockholm, Sweden), K. Che (Stockholm, Sweden), A. Linden (Stockholm, Sweden)
Parathyroid hormone: a neglected biomarker of exacerbations and hospitalizations in patients with COPD and hypovitaminosis D. C. Amado Diago (Santander (Cantabria), Spain), M. García-Unzueta (Santander (Cantabria), Spain), J. Agüero Calvo (Santander (Cantabria), Spain), P. Martín Audera (Santander (Cantabria), Spain), S. Tello Mena (Santander (Cantabria), Spain), S. Izquierdo Cuervo (Santander (Cantabria), Spain), G. Andretta Juarez (Santander (Cantabria), Spain), J. Osorio Chavez (Santander (Cantabria), Spain), M. Cristeto Porras (Santander (Cantabria), Spain), L. Gonzalez Ramos (Santander (Cantabria), Spain), N. Borja Vargas (Santander (Cantabria), Spain), A. Guerra (Santander (Cantabria), Spain), M. Ruiz De Infante Pérez (Santander (Cantabria), Spain), A. Berja (Santander (Cantabria), Spain)
Leveraging causal modeling to predict future COPD R. Gregg (Pittsburgh, United States of America), P. Benos (Pittsburgh, United States of America)
Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation. A. Cerezo Lajas (madrid, Spain), K. Liendo Martinez (madrid, Spain), S. Suarez Escudero (madrid, Spain), V. Gallo Gonzalez (madrid, Spain), L. Puente Maestu (madrid, Spain), J. De Miguel Diez (madrid, Spain)
Predicting an AECOPD from vital signs during daily life: insights from novel technology G. France (Leicester, United Kingdom), M. Richardson (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), D. Esliger (Loughborough, United Kingdom), S. Briggs-Price (Leicester, United Kingdom), E. Chaplin (Leicester, United Kingdom), L. Clinch (Leicester, United Kingdom), M. Steiner (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), M. Orme (Leicester, United Kingdom)
Usefullnes of chest computed tomography as a tool to predict COPD exacerbations J. Nunes Caldeira Marinho Matos (Coimbra, Portugal), S. Rodrigues Sousa (Coimbra, Portugal), L. Sousa Gomes (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal)
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Y. Zhang (Kyoto, Japan), N. Tanabe (Kyoto, Japan), H. Shima (Kyoto, Japan), Y. Shiraishi (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), S. Muro (Nara, Japan), S. Sato (Kyoto, Japan), T. Hirai (Kyoto, Japan)
Reversibility at pulmonary function tests: can it have implications in patients with COPD? K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine)
Airway resistance and characterization of airway obstruction R. Barros (Lisboa, Portugal), L. Raposo (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension B. Olha, O. Kovalenko (elen.rk@ukr.net / SI DMA,Dnipro), V. Rodionova (v.rodionova@i.ua / SI DMA,Dnipro)
Oxygen therapy within first 24 hours of admission in patients with COPD and risk of adverse events - an observational study C. Bech (Hvidovre, Denmark), J. Stæhr Jensen (København Ø, Denmark), E. Frausing-Hansen (København Ø, Denmark)
Late Breaking Abstract - Analysing the COPD care pathway in Japan, Canada, England and Germany: pilot study results A. Meiwald (London, United Kingdom), R. Gara-Adams (London, United Kingdom), Y. Ma (London, United Kingdom), M. Bhutani (Edmonton, Canada), M. Ichinose (Osaki, Japan), J. Scullion (Leicester, United Kingdom), H. Watz (Wöhrendamm, Germany), T. Wilkinson (Southampton, United Kingdom), G. Weston (London, United Kingdom), E. Adams (London, United Kingdom)
Late Breaking Abstract - The effect of comorbidity on the course and outcomes of COPD in observation in the primary health care, including on the background of the COVID-19 pandemic: a comparative analysis. E. Klester (Barnaul (Altai Region), Russian Federation), K. Klester (Barnaul (Altay), Russian Federation), V. Elykomov (Barnaul (Altay), Russian Federation), I. Anisimova (Barnaul (Altay), Russian Federation)
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients. P. Solidoro (Torino , Italy), F. Braido (Genova , Italy), M. Contoli (Ferrara, Italy), A. Corsico (Pavia, Italy), F. Di Marco (Bergamo, Italy), C. Micheletto (Verona, Italy), G. Pelaia (Catanzaro, Italy), P. Rogliani (Roma, Italy), L. Saderi (Sassari, Italy), N. Scichilone (Palermo, Italy), G. Sotgiu (Sassari, Italy), G. Manna (Basiglio, Italy), S. Boarino (Basiglio, Italy), P. Santus (Milano , Italy)